Ono Pharmaceutical Co (Ono Pharmaceutical Co) Change In Receivables : $-139 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Ono Pharmaceutical Co Change In Receivables?

Ono Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was $100 Mil. It means Ono Pharmaceutical Co's Accounts Receivable declined by $100 Mil from Dec. 2023 to Mar. 2024 .

Ono Pharmaceutical Co's change in receivables for the fiscal year that ended in Mar. 2024 was $-132 Mil. It means Ono Pharmaceutical Co's Accounts Receivable increased by $132 Mil from Mar. 2023 to Mar. 2024 .

Ono Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was $908 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ono Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 110.10.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ono Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was $1,441 Mil.

Ono Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Ono Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ono Pharmaceutical Co Change In Receivables Chart

Ono Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-7.37

-66.05

-128.89

-108.58

-132.04

Ono Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															69.62	-57.38	-120.94	-60.45	99.55

Ono Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-139 Mil.

Ono Pharmaceutical Co (OTCPK:OPHLY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ono Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	908.205	/	752.704	*	91
=	110.10

2. In Ben Graham's calculation of liquidation value, Ono Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Ono Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1365.618	-	768.015	+	0.75 * 908.205	+	0.5 * 324.586
=	1,441

Ono Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ono Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ono Pharmaceutical Co Ltd (OTCPK:OPHLY) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

OPHLF:USA 4528:Japan ON4:Germany

Address

8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, JPN, 541-8564

Website

http://www.ono.co.jp

Ono Pharmaceutical is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. It maintains a global business in specialty pharmaceuticals. The company breaks out its revenue of goods and products into eight segments. The vast majority of Ono's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of Ono's sales are generated in Japan, followed by the rest of Asia and Europe.

Ono Pharmaceutical Co (Ono Pharmaceutical Co) Headlines

From GuruFocus

T. Rowe Price Japan Fund Purchases 5 Stocks in 3rd Quarter

By Holly LaFon Holly LaFon • 10-18-2017

Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million

By PRNewswire • 12-01-2023

Ono Pharmaceutical Co Stock Appears To Be Modestly Undervalued

By GF Value • 07-05-2021

Samuel Isaly's Eaton Vance Worldwide Health Sciences Fund Q1 Investment Report

By Holly LaFon Holly LaFon • 05-13-2016